Never too late: Forbion pitches $100M SPAC; Kronos Bio releases early interim data on CDK9 inhibitor
Dutch VC Forbion is hopping on the ever-lengthening SPAC train.
To be led by Jasper Bos, who joined Forbion Growth as a general partner back …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
